Lybradyn

News & Press

 

“Lybradyn’s first technology spinoff company, Proterro, makes its entrance into the biofuels market through its unique process for producing economical feedstock sugars.”

NY Times/Venture Beat-Green Beat:  Read More

Biofuels Digest:  Read More

 

Congressman Peter Roskam announces support for Lybradyn anti-biofilm technology

Congressman Peter J. Roskam (R-IL) today announced a $133,000 grant from the National Institute of Allergy and Infectious Diseases (NIAID) in support of Lybradyn Incorporated’s Anti-Infectives Research in Oak Brook.

Read More.

 

Lybradyn participates with the iBIO Propel Program

Looking for a way to combat chemical warfare, a local firm also may have found a powerful new antibiotic, thanks to a little help from its mentor friends in Chicago's biotech community.

The biocatalyst developed by Oak Brook-based Lybradyn Inc. works by interfering with the chemical signals microbes use to communicate. The thinking is that if bacteria cannot communicate, they can't know where or how to congregate. And if they cannot congregate, their ability to spread infection would decrease dramatically. The firm recently won a federal grant to develop its discovery.

Read More.

 

Lybradyn awarded DECO/iBIO matching grant to develop alternative energy technology

John Aikens, VP of Lybradyn, a biotechnology company based in Oak Brook, Ill., explains. “Plants have the limitation that you have to cultivate, fertilize, harvest and process them,” he says. “In addition, crops use a lot of land, all of which requires consumption of petroleum fuel.” The challenge, therefore, is to determine how to minimize the amount of energy needed to create a BTU.

Read More.

 

C&En News: Lybradyn showcases expertise in chemical weapons decontamination technology

If they are not starting new companies, former MediChem people are joining other new Chicago-area firms. One is Lybradyn, a biotechnology company that is developing products through the integration of genetic engineering and fermentation.

Read More.

 

Lybradyn technologies developed through SBIR/STTR grant awards

  • 1R43CA106036-01 Novel Racemases for Enzymatic Dynamic Kinetic Resolution
  • 1R41GM072357-01 Novel Organophosphorous Hydrolases for Decontamination
  • 2R42GM072357-02 Novel Organophosphorous Hydrolases for Decontamination
  • 1R43AI80010-01 Biocatalytic Inhibition of Quorum Signaling
 


Lybradyn technology in peer reviewed technical literature